pre-miRNA Information
pre-miRNA hsa-mir-155   
Genomic Coordinates chr21: 25573980 - 25574044
Description Homo sapiens miR-155 stem-loop
Comment Human mir-155 is predicted based on homology to a cloned miR from mouse (MIR:MI0000177) .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-155-3p
Sequence 43| CUCCUACAUAUUAGCAUUAACA |64
Evidence Experimental
Experiments Cloned
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1181188719 6 dbSNP
rs759895287 7 dbSNP
rs200351615 8 dbSNP
rs377265631 10 dbSNP
rs1038360714 20 dbSNP
Putative Targets

miRNA Expression profile
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BA4I1F miR-155 Safety Biomarker (SAF) Clinical/Experimental Data Expression Decrease Blood and urinary supernatants Quantitative real-time PCR
BA4I1F miR-155 Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Kidney tissue Quantitative real-time PCR
Gene Information
Gene Symbol DNAJA1   
Synonyms DJ-2, DjA1, HDJ2, HSDJ, HSJ-2, HSJ2, HSPF4, NEDD7, hDJ-2
Description DnaJ heat shock protein family (Hsp40) member A1
Transcript NM_001539   
Expression
Putative miRNA Targets on DNAJA1
3'UTR of DNAJA1
(miRNA target sites are highlighted)
>DNAJA1|NM_001539|3'UTR
   1 TGGGCCAGTGAATAACACTCACTGCTGGCATTTAATGTGCAGTAGTGAATGAGTGAAGGACTGTAATCATAATATGCTCA
  81 CTACTTGCTCTTGTTTTTGTTTTAATAAACTATAGTAGTGTTTTAAAAAGTTAAATGAAGAATAAACGCAAATATAAAAG
 161 CTCTGATTTTGCCCTGTATGTATGATGACTTCAGTGTGCAAGATGAAGTTTAATACCTGTAAAAACTACAAAGAAGTTCC
 241 CCTAGCATTTCTAGGCCAAACCTTGTAATTGACTTCAGCTATGTACGTGGACAAGCTTAGACTGAAATGCTAGGTATATG
 321 TATTGGCTTCAGTGTATGACCCTTCATTGTTAAGCTATGAAAGTAAAACTCTGTATTTAACTGGCAATGAGGAAAAAAAA
 401 ATTTTGTAGAGAAGTGTTGGTCTGTATAGTTCTTTATATTAAGTGGGATTCATTGTAATGCCTCTGCATTTATTCTGTTG
 481 CCTCAGCTGTTACTTGAAGATGGCGTAATATATAATTTATCCTGTGGTATCAGTGATAAAAATGATACCTTTCTGTAGGA
 561 GGGGTTTATCATAATATGCTGCTTCTTGAAGGCTTGCACTTCCAGAATTGTGTTTCCTTCTGCTGTGCCATTCATATATA
 641 TATACATATATATATATAATCTTGACCAGTCCTGGTCATTTGCTCCCCTCCTTGTCTGTGGACCATGATAAGCCCAAGTA
 721 GTGACTTCAGAGCTGGGTAACAGAAATTAAAGTGAAAAGACCTTTACGTGGAGAATTTGCATGCGTAATATAGGAAGGTG
 801 TTCTTTAGGTATGTTACAGGATTACTTTAAACCATTTGACTTTCGCTCCAAAGTTATGTTGGTAGTATAGCAAATTATGA
 881 TGAATAGCTTTAATTGTATGTTTAAAAGTCTCATATGTTCACATGCTTAAATCTGGGTATCAGAATTTAAGCAATTCTTG
 961 AAATGTATTGTCTCCTTAATATACTAATTACAAAGCATCTCCAAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' acaaUUACGAU---UAUACAUCCUc 5'
              |||| ||    | ||||||| 
Target 5' taaaAATGATACCTTTCTGTAGGAg 3'
537 - 561 154.00 -12.26
2
miRNA  3' acAAU-UACG-AUUAUACAUCCUc 5'
            ||: |||| ||  || ||||| 
Target 5' atTTGCATGCGTA--ATATAGGAa 3'
775 - 796 128.00 -8.20
3
miRNA  3' acaAUUACGAUUA--UACAUCCUc 5'
             ||:||  |||  :|| |||| 
Target 5' cagTAGTG--AATGAGTGAAGGAc 3'
40 - 61 125.00 -7.60
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN31482200 21 COSMIC
COSN6389584 26 COSMIC
COSN31581448 73 COSMIC
COSN28875445 127 COSMIC
COSN23629191 410 COSMIC
COSN17021155 646 COSMIC
COSN21313385 760 COSMIC
COSN21485422 788 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1375108142 1 dbSNP
rs770904664 2 dbSNP
rs1304746476 3 dbSNP
rs776768067 7 dbSNP
rs781143779 10 dbSNP
rs745449469 12 dbSNP
rs1275915125 13 dbSNP
rs1311169512 15 dbSNP
rs747015712 17 dbSNP
rs769521508 19 dbSNP
rs774816290 20 dbSNP
rs1183968380 21 dbSNP
rs762575235 23 dbSNP
rs1456257632 33 dbSNP
rs1004514057 34 dbSNP
rs1234672839 35 dbSNP
rs1177794678 36 dbSNP
rs1330186885 38 dbSNP
rs1247171442 40 dbSNP
rs772428402 47 dbSNP
rs1170834464 51 dbSNP
rs773775893 56 dbSNP
rs1321123173 58 dbSNP
rs1466245286 60 dbSNP
rs1161559011 62 dbSNP
rs755505219 62 dbSNP
rs1385041317 64 dbSNP
rs1413215585 69 dbSNP
rs1398406414 70 dbSNP
rs1446457620 71 dbSNP
rs761015443 72 dbSNP
rs766672756 73 dbSNP
rs754232780 75 dbSNP
rs759627222 76 dbSNP
rs765543456 80 dbSNP
rs1343627660 82 dbSNP
rs752685836 83 dbSNP
rs1386719761 85 dbSNP
rs1259531668 91 dbSNP
rs1376182287 91 dbSNP
rs1477876197 91 dbSNP
rs758568855 93 dbSNP
rs374511744 95 dbSNP
rs1337735657 103 dbSNP
rs759112229 104 dbSNP
rs11542818 115 dbSNP
rs990381230 122 dbSNP
rs7296 124 dbSNP
rs1211363540 128 dbSNP
rs1373584184 132 dbSNP
rs945405184 134 dbSNP
rs114496815 141 dbSNP
rs1277020589 148 dbSNP
rs1397544630 149 dbSNP
rs1300604073 155 dbSNP
rs1313997421 158 dbSNP
rs1414298151 161 dbSNP
rs1346535318 172 dbSNP
rs1400513759 175 dbSNP
rs1169928352 176 dbSNP
rs1211421197 180 dbSNP
rs534448067 181 dbSNP
rs1475872695 183 dbSNP
rs554132326 185 dbSNP
rs1423101434 190 dbSNP
rs1191644135 191 dbSNP
rs1476201856 197 dbSNP
rs1469864602 205 dbSNP
rs911868218 209 dbSNP
rs577470498 226 dbSNP
rs1435813321 229 dbSNP
rs1441686706 240 dbSNP
rs1276257349 243 dbSNP
rs1339696084 245 dbSNP
rs944691471 247 dbSNP
rs1042345 252 dbSNP
rs900750633 253 dbSNP
rs539421217 265 dbSNP
rs1447930084 274 dbSNP
rs1339166591 282 dbSNP
rs556610012 287 dbSNP
rs1192052048 288 dbSNP
rs1049187204 294 dbSNP
rs1463117678 296 dbSNP
rs1394498307 297 dbSNP
rs1454768367 298 dbSNP
rs1472427031 303 dbSNP
rs886206422 311 dbSNP
rs1183751617 317 dbSNP
rs1004558138 319 dbSNP
rs1196360296 327 dbSNP
rs1023992639 330 dbSNP
rs971107715 337 dbSNP
rs767886244 342 dbSNP
rs1227182436 351 dbSNP
rs1354903006 369 dbSNP
rs1281737045 370 dbSNP
rs1001605446 372 dbSNP
rs1376589749 374 dbSNP
rs759928022 376 dbSNP
rs1443392478 379 dbSNP
rs1329931014 391 dbSNP
rs1323003368 393 dbSNP
rs1356698609 393 dbSNP
rs1443848379 396 dbSNP
rs1403628419 399 dbSNP
rs1411598344 401 dbSNP
rs576537888 402 dbSNP
rs757519062 402 dbSNP
rs957480914 402 dbSNP
rs542317825 403 dbSNP
rs1469538433 412 dbSNP
rs966799090 416 dbSNP
rs1220219950 417 dbSNP
rs978200512 422 dbSNP
rs911961620 425 dbSNP
rs1241505227 427 dbSNP
rs944766159 428 dbSNP
rs1305053866 437 dbSNP
rs778814654 441 dbSNP
rs1236895172 454 dbSNP
rs1368596492 463 dbSNP
rs758807285 468 dbSNP
rs975144598 468 dbSNP
rs1347033975 469 dbSNP
rs1320273309 474 dbSNP
rs1420247447 474 dbSNP
rs1213983538 476 dbSNP
rs1359748553 477 dbSNP
rs1156647387 478 dbSNP
rs1455383374 483 dbSNP
rs1273430348 496 dbSNP
rs1425494519 499 dbSNP
rs1190244605 505 dbSNP
rs922217104 506 dbSNP
rs1216613192 512 dbSNP
rs930852886 513 dbSNP
rs1213527668 515 dbSNP
rs1284436936 515 dbSNP
rs1211986839 523 dbSNP
rs190382879 534 dbSNP
rs1252646744 537 dbSNP
rs1468932651 541 dbSNP
rs1195562099 544 dbSNP
rs1240475587 545 dbSNP
rs1475364194 546 dbSNP
rs1169007505 549 dbSNP
rs1422009564 550 dbSNP
rs1460231220 551 dbSNP
rs1162284279 553 dbSNP
rs1421150238 562 dbSNP
rs1193776149 566 dbSNP
rs1477195000 571 dbSNP
rs1261704989 574 dbSNP
rs1049230870 577 dbSNP
rs796515746 582 dbSNP
rs574675150 585 dbSNP
rs1441231581 591 dbSNP
rs1327326226 598 dbSNP
rs1309519491 603 dbSNP
rs780530305 604 dbSNP
rs534901083 609 dbSNP
rs146021760 611 dbSNP
rs1270704379 613 dbSNP
rs1341165197 615 dbSNP
rs1231255824 618 dbSNP
rs1272375390 620 dbSNP
rs1335694585 626 dbSNP
rs1302075856 632 dbSNP
rs1445475698 632 dbSNP
rs906938513 632 dbSNP
rs537309585 633 dbSNP
rs1245559024 634 dbSNP
rs1275145216 634 dbSNP
rs1322277608 634 dbSNP
rs201643498 634 dbSNP
rs1311886323 636 dbSNP
rs541836605 636 dbSNP
rs1378830124 638 dbSNP
rs1446502180 638 dbSNP
rs893072377 640 dbSNP
rs1294807798 642 dbSNP
rs768269278 642 dbSNP
rs1457927891 644 dbSNP
rs146004118 644 dbSNP
rs560140690 645 dbSNP
rs1042376 646 dbSNP
rs1165577892 646 dbSNP
rs1255062311 647 dbSNP
rs1419115000 647 dbSNP
rs1488178886 650 dbSNP
rs552224366 650 dbSNP
rs1264862009 651 dbSNP
rs1238670765 653 dbSNP
rs562122994 653 dbSNP
rs1309719717 654 dbSNP
rs1355694485 654 dbSNP
rs1239111291 655 dbSNP
rs755027166 656 dbSNP
rs1019065931 658 dbSNP
rs1215783765 658 dbSNP
rs1389386518 659 dbSNP
rs74178844 659 dbSNP
rs1292355535 660 dbSNP
rs1361662317 661 dbSNP
rs1197371387 662 dbSNP
rs1158438972 668 dbSNP
rs1461627512 670 dbSNP
rs1379627887 672 dbSNP
rs1164651009 676 dbSNP
rs1432732872 686 dbSNP
rs1265374624 692 dbSNP
rs1382060895 697 dbSNP
rs1206904681 706 dbSNP
rs1489247968 716 dbSNP
rs1399649043 717 dbSNP
rs112767677 721 dbSNP
rs974775828 722 dbSNP
rs1257463424 726 dbSNP
rs1342273158 731 dbSNP
rs553570205 736 dbSNP
rs1292448530 742 dbSNP
rs547875231 743 dbSNP
rs568639901 749 dbSNP
rs1355865850 750 dbSNP
rs1298568394 762 dbSNP
rs1401264163 763 dbSNP
rs921897474 768 dbSNP
rs1259214171 769 dbSNP
rs1418325564 773 dbSNP
rs756709286 779 dbSNP
rs567827643 785 dbSNP
rs534088291 786 dbSNP
rs985028850 790 dbSNP
rs1376091600 792 dbSNP
rs908130383 795 dbSNP
rs1478176527 799 dbSNP
rs529924885 807 dbSNP
rs1192851866 808 dbSNP
rs1445128251 809 dbSNP
rs1280493806 816 dbSNP
rs1200756873 818 dbSNP
rs1343897754 819 dbSNP
rs1253858749 822 dbSNP
rs1219974022 826 dbSNP
rs1317993343 827 dbSNP
rs1210867978 829 dbSNP
rs369360190 837 dbSNP
rs1398708442 840 dbSNP
rs940895707 844 dbSNP
rs540399833 845 dbSNP
rs1400397349 849 dbSNP
rs571019678 858 dbSNP
rs1466271838 863 dbSNP
rs1168556505 865 dbSNP
rs1422995865 865 dbSNP
rs1474389854 867 dbSNP
rs1361729687 870 dbSNP
rs937062634 874 dbSNP
rs1441597813 877 dbSNP
rs1240956208 878 dbSNP
rs1055478202 883 dbSNP
rs892823425 897 dbSNP
rs1256872865 907 dbSNP
rs1011228545 913 dbSNP
rs1361984658 917 dbSNP
rs1436983857 917 dbSNP
rs540106753 919 dbSNP
rs1285280336 924 dbSNP
rs1339075588 925 dbSNP
rs560649342 925 dbSNP
rs1333686063 933 dbSNP
rs1375791057 936 dbSNP
rs1399750097 937 dbSNP
rs903095933 946 dbSNP
rs138583305 958 dbSNP
rs1415920931 959 dbSNP
rs1163764240 961 dbSNP
rs1472375717 961 dbSNP
rs1383167765 964 dbSNP
rs1019829157 967 dbSNP
rs1457956681 975 dbSNP
rs1397583636 980 dbSNP
rs1304660316 983 dbSNP
rs1452804735 994 dbSNP
rs1291309090 999 dbSNP
rs1209756023 1005 dbSNP
rs1357853103 1005 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection ...

- Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell.

miRNA-target interactions (Provided by authors)
ID Duplex structure Position
1
miRNA  3' acaauuacgauuauacAUCCUc 5'
                          ||||| 
Target 5' ----------------UAGGAg 3'
1 - 6
Article - Hafner M; Landthaler M; Burger L; Khorshid et al.
- Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
Experimental Support 2 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions HEK293
Disease 3301.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "HITS-CLIP data was present in GSM714642. RNA binding protein: AGO2. Condition:completeT1 "PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1 "PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1 ...

- Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods.

Article - Kishore S; Jaskiewicz L; Burger L; Hausser et al.
- Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
Experimental Support 3 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293
Disease 3301.0
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... "PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine "PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine "PAR-CLIP data was present in GSM1065669. RNA binding protein: AGO1. Condition:4-thiouridine ...

- Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature.

Article - Memczak S; Jens M; Elefsinioti A; Torti F; et al.
- Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
Experimental Support 4 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions MCF7
Location of target site 3'UTR
Tools used in this research TargetScan , miRTarCLIP , Piranha
Original Description (Extracted from the article) ... PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated ...

- Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology.

Article - Farazi TA; Ten Hoeve JJ; Brown M; et al.
- Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
CLIP-seq Support 1 for dataset GSM714642
Method / RBP HITS-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 2 for dataset GSM545216
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / miR-124 transfection
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 20371350 / GSE21578
CLIP-seq Viewer Link
CLIP-seq Support 3 for dataset GSM714644
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repA
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUGAAG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 4 for dataset GSM714645
Method / RBP PAR-CLIP / AGO2
Cell line / Condition HEK293 / completeT1, repB
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 21572407 / GSE28865
CLIP-seq Viewer Link
CLIP-seq Support 5 for dataset GSM1065667
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_6
Location of target site ENST00000330899.4 | 3UTR | UGUAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 6 for dataset GSM1065668
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_7
Location of target site ENST00000330899.4 | 3UTR | AGGAGGGGUUUAUCAUAAUAUGCUGCUUCU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 7 for dataset GSM1065669
Method / RBP PAR-CLIP / AGO1
Cell line / Condition HEK293 / 4-thiouridine, ML_MM_8
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUU
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 23446348 / GSE43573
CLIP-seq Viewer Link
CLIP-seq Support 8 for dataset SRR1045082
Method / RBP PAR-CLIP / AGO2
Cell line / Condition MCF7 / Untreated
Location of target site ENST00000330899.4 | 3UTR | UAGGAGGGGUUUAUCAUAAUAUGCUGCUUCUUG
Tools used in this analysis TargetScan, miRTarCLIP, and Piranha
Article / Accession Series PMID: 24398324 / SRX388831
CLIP-seq Viewer Link
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
GSE26953 Aortic valvular endothelial cells -0.433 1.7e-2 -0.403 2.5e-2 24 Click to see details
GSE28544 Breast cancer -0.3 7.7e-2 -0.330 5.8e-2 24 Click to see details
GSE19350 CNS germ cell tumors -0.406 9.5e-2 0.026 4.7e-1 12 Click to see details
GSE38226 Liver fibrosis -0.204 1.9e-1 -0.109 3.2e-1 21 Click to see details
GSE32688 Pancreatic cancer -0.157 2.0e-1 -0.041 4.1e-1 32 Click to see details
GSE15076 Monocyte-derived dendritic cells 0.426 2.0e-1 0.771 3.6e-2 6 Click to see details
GSE34608 Pulmonary tuberculosis and sarcoidosis 0.177 2.3e-1 -0.218 1.8e-1 20 Click to see details
GSE17498 Multiple myeloma -0.114 2.4e-1 -0.034 4.2e-1 40 Click to see details
GSE19536 Breast cancer 0.069 2.5e-1 0.069 2.5e-1 100 Click to see details
GSE19783 ER- ER- breast cancer 0.064 2.9e-1 0.042 3.6e-1 79 Click to see details
GSE28260 Renal cortex and medulla -0.143 3.2e-1 -0.115 3.5e-1 13 Click to see details
GSE42095 Differentiated embryonic stem cells 0.091 3.4e-1 0.150 2.5e-1 23 Click to see details
GSE38974 Chronic obstructive pulmonary disease 0.071 3.7e-1 0.043 4.2e-1 25 Click to see details
GSE19783 ER+ ER+ breast cancer -0.017 4.7e-1 -0.018 4.7e-1 20 Click to see details
GSE21687 Ependynoma primary tumors 0.006 4.8e-1 0.059 3.2e-1 64 Click to see details
GSE21687 Ependynoma primary tumors 0.006 4.8e-1 0.059 3.2e-1 64 Click to see details
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
LUSC 0.385 0.05 0.202 0.2 20 Click to see details
ESCA 0.852 0.07 1.000 0.5 4 Click to see details
LIHC 0.387 0.1 0.379 0.1 13 Click to see details
STAD 0.34 0.14 0.636 0.01 12 Click to see details
UCEC 0.494 0.2 0.100 0.44 5 Click to see details
BRCA 0.219 0.22 0.107 0.35 15 Click to see details
PAAD -0.462 0.27 -0.800 0.1 4 Click to see details
PRAD -0.229 0.36 -0.300 0.31 5 Click to see details
HNSC -0.077 0.39 -0.176 0.26 16 Click to see details
CHOL 0.335 0.39 0.500 0.33 3 Click to see details
KIRC -0.094 0.4 -0.164 0.33 10 Click to see details
KIRP -0.083 0.45 0.100 0.44 5 Click to see details
THCA 0.014 0.47 0.050 0.41 23 Click to see details
THCA 0.014 0.47 0.050 0.41 23 Click to see details
THCA 0.014 0.47 0.050 0.41 23 Click to see details
THCA 0.014 0.47 0.050 0.41 23 Click to see details
73 hsa-miR-155-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT005808 IRAK3 interleukin 1 receptor associated kinase 3 4 1
MIRT082844 ZNF460 zinc finger protein 460 2 4
MIRT256047 UBE2K ubiquitin conjugating enzyme E2 K 2 4
MIRT437787 PTEN phosphatase and tensin homolog 2 1
MIRT456168 ZDHHC6 zinc finger DHHC-type containing 6 2 2
MIRT464916 TXNIP thioredoxin interacting protein 2 4
MIRT475559 HNRNPF heterogeneous nuclear ribonucleoprotein F 2 2
MIRT499608 DNAJA1 DnaJ heat shock protein family (Hsp40) member A1 2 8
MIRT504220 MYO6 myosin VI 2 4
MIRT504256 C1orf147 chromosome 1 open reading frame 147 2 4
MIRT507642 CREBRF CREB3 regulatory factor 2 2
MIRT522858 KIAA1551 KIAA1551 2 2
MIRT527505 MYD88 myeloid differentiation primary response 88 5 2
MIRT530713 ORMDL3 ORMDL sphingolipid biosynthesis regulator 3 2 2
MIRT532851 ZNF699 zinc finger protein 699 2 2
MIRT535952 MIA3 MIA family member 3, ER export factor 2 2
MIRT539041 ATXN1L ataxin 1 like 2 4
MIRT556391 LUC7L LUC7 like 2 2
MIRT558617 CNOT6L CCR4-NOT transcription complex subunit 6 like 2 2
MIRT559869 ATXN3 ataxin 3 2 2
MIRT569208 SHC3 SHC adaptor protein 3 2 2
MIRT573122 C18orf25 chromosome 18 open reading frame 25 2 2
MIRT575076 Ddit4 DNA-damage-inducible transcript 4 2 2
MIRT607597 ABCF3 ATP binding cassette subfamily F member 3 2 6
MIRT609386 PHEX phosphate regulating endopeptidase homolog X-linked 2 2
MIRT610550 MDN1 midasin AAA ATPase 1 2 2
MIRT612390 TCF7L2 transcription factor 7 like 2 2 2
MIRT612910 GTDC1 glycosyltransferase like domain containing 1 2 6
MIRT613314 ARL5C ADP ribosylation factor like GTPase 5C 2 2
MIRT613356 ADAMTS5 ADAM metallopeptidase with thrombospondin type 1 motif 5 2 4
MIRT613541 CLMP CXADR like membrane protein 2 2
MIRT617029 SYT6 synaptotagmin 6 2 2
MIRT618044 MRVI1 murine retrovirus integration site 1 homolog 2 2
MIRT619307 KIRREL kirre like nephrin family adhesion molecule 1 2 2
MIRT623209 MTFR1L mitochondrial fission regulator 1 like 2 2
MIRT625448 RANGAP1 Ran GTPase activating protein 1 2 2
MIRT634551 MACC1 MACC1, MET transcriptional regulator 2 2
MIRT640740 EPB41 erythrocyte membrane protein band 4.1 2 2
MIRT640906 RAB13 RAB13, member RAS oncogene family 2 2
MIRT644025 ZNF792 zinc finger protein 792 2 2
MIRT651489 WT1 Wilms tumor 1 2 2
MIRT652037 LINC00598 long intergenic non-protein coding RNA 598 2 2
MIRT669093 CDK6 cyclin dependent kinase 6 2 2
MIRT696720 WNT3 Wnt family member 3 2 2
MIRT698085 TPM1 tropomyosin 1 2 2
MIRT703284 GID4 GID complex subunit 4 homolog 2 2
MIRT707183 ARHGEF33 Rho guanine nucleotide exchange factor 33 2 2
MIRT710362 CREB5 cAMP responsive element binding protein 5 2 2
MIRT713501 DCAF17 DDB1 and CUL4 associated factor 17 2 2
MIRT717153 LRRC3C leucine rich repeat containing 3C 2 2
MIRT719038 ATP1A1 ATPase Na+/K+ transporting subunit alpha 1 2 2
MIRT719489 LSG1 large 60S subunit nuclear export GTPase 1 2 2
MIRT720284 DPYSL3 dihydropyrimidinase like 3 2 2
MIRT732474 NLRP3 NLR family pyrin domain containing 3 2 0
MIRT732620 MS multiple sclerosis 1 0
MIRT732968 TGFBR2 transforming growth factor beta receptor 2 3 0
MIRT733063 AGTR1 angiotensin II receptor type 1 3 0
MIRT733206 ADAM10 ADAM metallopeptidase domain 10 1 0
MIRT733302 CRP C-reactive protein 2 0
MIRT734202 PDCD4 programmed cell death 4 3 0
MIRT734467 SIRT1 sirtuin 1 2 0
MIRT734701 Foxo3 forkhead box O3 1 0
MIRT734889 SP4 Sp4 transcription factor 2 0
MIRT735047 BATF basic leucine zipper ATF-like transcription factor 1 0
MIRT735048 SPI1 Spi-1 proto-oncogene 1 0
MIRT735734 PICALM phosphatidylinositol binding clathrin assembly protein 3 0
MIRT735944 TNF tumor necrosis factor 1 0
MIRT736131 MYLK myosin light chain kinase 2 0
MIRT736780 FOXP3 forkhead box P3 1 0
MIRT736781 CEBPB CCAAT/enhancer binding protein beta 1 0
MIRT736858 WEE1 WEE1 G2 checkpoint kinase 2 0
MIRT736873 TLR3 toll like receptor 3 2 0
MIRT736902 CFH complement factor H 2 0
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-155 Curcumin NULL 969516 Microarray apoE−/− mice 22253797 2012 down-regulated
miR-155 Cyclophosphamide approved 2907 Quantitative real-time PCR p53+/+ pregnant mice 20170545 2010 down-regulated
miR-155 Estrogen NULL NULL Microarray mouse uterus 20720260 2010 up-regulated
miR-155 Estrogen NULL NULL Quantitative real-time PCR mouse uterus 20720260 2010 up-regulated
miR-155 Camptothecin NULL 24360 Microarray human cancer cells 24252850 2014 down-regulated
miR-155 Cocaine NULL 446220 Quantitative real-time PCR monocyte derived dendritic cells 24391808 2014 down-regulated
miR-155 Glucose NULL 5793 Microarray endothelial cells 24394957 2014 up-regulated
miR-155 Triptolide NULL 107985 Quantitative real-time PCR peripheral blood mononuclear cells (PBMCs) of RA (rheumatoid arthritis) 24909288 2014 down-regulated
miR-155 Medpor NULL NULL Microarray osteoblast-like cells line (MG-63) 18408260 2008 up-regulated
miR-155 Lithium (Li) approved 3028194 Quantitative real-time PCR lymphoblastoid cell lines (LCLs) 19254429 2009 up-regulated
miR-155 Vorinostat (SAHA) approved 5311 Microarray A549 human non-small cell lung cancer cells 19513533 2009 down-regulated
miR-155 Bisphenol A NULL 6623 Microarray immortalized cytotrophoblast cell lines HTR-8 20417706 2010 up-regulated
miR-155 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-155 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-155 Gemcitabine approved 60750 Quantitative real-time PCR pancreatic cancer 21738581 2011 down-regulated
miR-155 Trichostatin A (TSA) NULL 444732 Microarray apoptosis-resistant breast cancer cells 21971930 2011 up-regulated
miR-155 Arsenic trioxide approved 14888 Quantitative real-time PCR acute promyelocytic leukemia 22072212 2012 up-regulated
miR-155 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-155 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 up-regulated
miR-155 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 up-regulated
miR-155 Glucocorticoid NULL NULL Microarray RAW264.7 cells 22326887 2012 down-regulated
miR-155 5-Fluorouracil approved 3385 Microarray CNE cells 22614822 2012 up-regulated
miR-155 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-155 Glucocorticoid NULL NULL TaqMan low-density array Eosinophilic esophagitis 22815788 2012 up-regulated
miR-155 Adrenaline approved 5816 Quantitative real-time PCR colon cancer HT29 cells 23036199 2012 up-regulated
miR-155 Leptin NULL NULL Quantitative real-time PCR muscles 20800581 2010 down-regulated
miR-155 Morphine approved 5288826 Microarray human monocyte-derived macrophages (h-mdms) infection with HIV-1 20564181 2010 up-regulated
miR-155 Sinomenine NULL 5459308 Quantitative real-time PCR Colitis 24066068 2013 down-regualted
miR-155 Praziquantel approved 4891 Quantitative real-time PCR liver cell lines 25051829 2014 down-regualted
miR-155 Uric acid NULL 1175 Quantitative real-time PCR endothelial cells 23996753 2013 up-regualted
miR-155 Hydroxychloroquine approved 3652 Microarray mesangial cells 24121037 2013 down-regualted
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-155 Tripterygium wilfordii Hook F resistant tissue
hsa-mir-155 Doxorubicin 31703 NSC123127 approved resistant cell line (W1)
hsa-mir-155 Vincristine 5978 approved resistant cell line (W1)
hsa-mir-155 Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-155-3p Cisplatin 5460033 NSC119875 approved sensitive High Lung Adenocarcinoma cell line (A549)
hsa-miR-155-3p Oxaliplatin 6857599 NSC266046 approved sensitive High Colorectal Cancer cell line (HCT-116)
hsa-miR-155-3p Paclitaxel 36314 NSC125973 approved resistant High Non-Small Cell Lung Cancer cell line (H358, H1993)
hsa-miR-155-3p Paclitaxel 36314 NSC125973 approved sensitive Low Breast Cancer cell line (MCF-7, SKBR3, MDA-MB-231)
hsa-miR-155-3p Temozolomide 5394 NSC362856 approved resistant Low Glioblastoma cell line (A172, U87)
hsa-miR-155-3p Gefitinib 123631 NSC715055 approved sensitive cell line (PC9)
hsa-miR-155-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (PC9)
hsa-miR-155-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (HCC827)
hsa-miR-155-3p Gefitinib 123631 NSC715055 approved resistant cell line (HCC827)
hsa-miR-155-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardB)
hsa-miR-155-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-155-3p Neoadjuvant chemotherapy sensitive tissue (breast cancer)
hsa-miR-155-3p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide sensitive cell line (Bads-200)

Error report submission